0.0126
0.0000
(0.00%)
May 3 - Close
OTCBB
data delayed by 15 mins -
Disclaimer
Currency in USD
| Range | - |
| 52 week | 0.01 - 0.20 |
| Open | - |
| Vol / Avg. | 0.00/1,917.00 |
| Mkt cap | 3.45M |
| P/E | - |
| Div/yield | - |
| EPS | -0.02 |
| Shares | 274.09M |
| Beta | 24.95 |
| Inst. own | 19% |
Key stats and ratios
| Q3 (Sep '12) | 2011 | |
| Net profit margin | - | - |
| Operating margin | - | - |
| EBITD margin | - | - |
| Return on average assets | -70.50% | -449.86% |
| Return on average equity | -127.84% | - |
| Employees | 5 | - |
| Carbon Disclosure Rating | - | - |
Address
Suite 600, 15 Allstate Parkway
MARKHAM, ON L3R 5B4
Canada
+1-416-2469997 (Phone)
+1-866-2805239 (Fax)
MARKHAM, ON L3R 5B4
Canada
+1-416-2469997 (Phone)
+1-866-2805239 (Fax)
Website links
External links
Discussion Group - Google Finance
Advertisement
Description
Kallo Inc. (Kallo) is a development-stage company. The Company develops and sells software for doctors, radiologists and hospitals. The Company�s products include Electronic Medical Record System (EMR) called EMCURx. Emcurx is an informatics tool, which enables the physician to make informed diagnostic and therapeutic decisions at point of care. The system communicates with existing legacy systems including Admissions (ADT), pharmacy, laboratory, radiology and Picture Archival and Communication Systems (PACS) through Health Language 7 (HL-7) interfaces. Through its interfaces, EMR captures all clinical information available on every hospitalized patient at any given moment, representing the totality of data required by the hospital clinical staff to perform their duties.
Officers and directors
| John Cecil | Chairman of the Board, Chief Executive Officer, Principal Financial Officer, Principal Accounting Officer, Treasurer | |
| Vince Leitao | President, Chief Operating Officer, Director | |
| Samuel R. Baker QC | Corporate Secretary, Director | |
| Lloyd A. Chiotti | Director |